Nautilus Biotechnology, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-39.2M | $-41.5M | $2.3M | $7.9M |
| FY2022 | $-45.8M | $-48.1M | $2.3M | $10.4M |
| FY2023 | $-51.7M | $-54.2M | $2.4M | $12.1M |
| FY2024 | $-59.1M | $-61.3M | $2.1M | $12.7M |
| FY2025 | $-50.7M | $-52.0M | $1.3M | $6.8M |